• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[骨骼闪烁扫描及一些骨转换标志物在血液透析患者肾性骨营养不良诊断中的应用]

[Skeletal scintigraph and some bone turnover markers in the diagnosis of renal osteodystrophy in hemodialysis patients].

作者信息

Bednarek-Skublewska Anna, Chrapko Beata, Ksiazek Andrzej

机构信息

Katedra i Klinika Nefrologii AM w Lublinie.

出版信息

Pol Arch Med Wewn. 2003 Sep;110(3):943-50.

PMID:14699686
Abstract

UNLABELLED

Real osteodystrophy is a spectrum of bone disorders that developing in patients (pts) with chronic renal failure. In the recent years several new biochemical markers of bone turnover have been proposed for the non-invasive evaluation of bone remodeling in hemodialysis (HD) pts The aim of our study was to examine serum concentrations (conc.) of some biochemical parameters of bone turnover and compare them with the results of bone scintigraphy. We measured serum levels of the aminoterminal propeptide of type I procollagen (PINP) as a marker of bone formation, and the serum levels of the pyridinoline cross-linked telopeptide domain of type I collagen (ICTP) as a marker of bone resorption in a group of 71 HD pts (35 male, 36 female) with a mean age 56 years. The mean duration of treatment was 87 months (range 2-302). We have compared these two collagen related peptides with more classical humoral parameters of renal osteodystrophy. For that purpose we measured serum concentrations of: intact PTH (iPTH), osteocalcin (BGP) and hydroxyproline (Hyd). The control group (CG) consisted of 22 healthy subjects, mean age 41 years. Whole-body bone scintigraphy was performed 2.5 hours after injection of 740 MBq MDP99mTc. The quantification of bone images was performed using bone to soft tissue ratio K. The mean conc. of PINP were significantly higher in HD pts than in CG (170.0 +/- 125.4 vs 32.3 +/- 9.3 micrograms/L, p < 0.001). Likewise and mean conc. of ICTP were significantly higher in pts than in CG (53.3 +/- 14.2 vs 2.9 +/- 0.7 micrograms/L, p < 0.001). We observed that mean conc. of iPTH were significantly higher in pts than in CG (575.7 +/- 569.6 vs 32.3 +/- 9.4 pg/ml; p < 0.001). Also the mean conc. of Hyd and BCG were higher than in CG (305.3 +/- 95.3 vs 281.5 +/- 53.9 mumoL, p < 0.05 and respectively 58.6 +/- 27.2 vs 7.4 +/- 2.7 ng/ml, p < 0.001). K ratio was significantly higher in patients than in control group (GK) (3.7 +/- 1.2 vs 2.2 +/- 0.5, p < 0.01). Some significant positive correlations were observed between: PINP and ICTP (r = 0.71, p < 0.000001); between: PTH and PINP (r = 0.83, p < 0.000001) and between: PTH and ICTP (r = 0.49, p < 0.00002). We found significant positive correlation between: BGP and PINP (r = 0.83, p < 0.000001) and between: BGP and ICTP (r = 0.57, p < 0.0001). No correlation was found between serum Hyd levels and other examined biochemical markers of bone turnover in our group of pts. Significant correlations were found also between K ratio on one hand and PINP (p < 0.01, r = 0.575) and BGP (p < 0.01, r = 0.535) levels on the other. The correlation between K ratio and iPTH was slightly significant (p = 0.05, r = 0.462). We did not find any relationship between other parameters.

CONCLUSION

We concluded that PINP, ICTP and semiquantative bone scan evaluation are good diagnostic tools in the process of bone turnover in hemodialysis patients. The long duration of hemodialysis therapy is connected with higher plasma levels of ICTP--marker of bone resorption.

摘要

未标记

真性骨营养不良是慢性肾衰竭患者发生的一系列骨骼疾病。近年来,人们提出了几种新的骨转换生化标志物,用于对血液透析(HD)患者的骨重塑进行无创评估。我们研究的目的是检测一些骨转换生化参数的血清浓度,并将其与骨闪烁显像结果进行比较。我们测量了一组71例HD患者(35例男性,36例女性)的血清I型前胶原氨基端前肽(PINP)水平作为骨形成标志物,以及血清I型胶原吡啶啉交联端肽结构域(ICTP)水平作为骨吸收标志物,这些患者的平均年龄为56岁。平均治疗时间为87个月(范围2 - 302个月)。我们将这两种与胶原相关的肽与肾性骨营养不良更经典的体液参数进行了比较。为此,我们测量了血清中完整甲状旁腺激素(iPTH)、骨钙素(BGP)和羟脯氨酸(Hyd)的浓度。对照组(CG)由22名健康受试者组成,平均年龄41岁。在注射740 MBq 99mTc - MDP后2.5小时进行全身骨闪烁显像。使用骨与软组织比值K对骨图像进行定量分析。HD患者中PINP的平均浓度显著高于CG(170.0±125.4 vs 32.3±9.3微克/升,p < 0.001)。同样,患者中ICTP的平均浓度也显著高于CG(53.3±14.2 vs 2.9±0.7微克/升,p < 0.001)。我们观察到患者中iPTH的平均浓度显著高于CG(575.7±569.6 vs 32.3±9.4皮克/毫升;p < 0.001)。此外,Hyd和BCG的平均浓度也高于CG(305.3±95.3 vs 281.5±53.9微摩尔,p < 0.05;分别为58.6±27.2 vs 7.4±2.7纳克/毫升,p < 0.001)。患者的K比值显著高于对照组(CG)(3.7±1.2 vs 2.2±0.5,p < 0.01)。在以下各项之间观察到一些显著的正相关:PINP与ICTP(r = 0.71,p < 0.000001);PTH与PINP(r = 0.83,p < 0.000001)以及PTH与ICTP(r = 0.49,p < 0.00002)。我们发现:BGP与PINP(r = 0.83,p < 0.000001)以及BGP与ICTP(r = 0.57,p < 0.0001)之间存在显著正相关。在我们的患者组中,血清Hyd水平与其他检测的骨转换生化标志物之间未发现相关性。在K比值与PINP(p < 0.01,r = 0.575)以及BGP(p < 0.01,r = 0.535)水平之间也发现了显著相关性。K比值与iPTH之间的相关性略显显著(p = 0.05,r = 0.462)。我们未发现其他参数之间存在任何关系。

结论

我们得出结论,PINP、ICTP和半定量骨扫描评估是血液透析患者骨转换过程中的良好诊断工具。血液透析治疗时间长与骨吸收标志物ICTP的血浆水平升高有关。

相似文献

1
[Skeletal scintigraph and some bone turnover markers in the diagnosis of renal osteodystrophy in hemodialysis patients].[骨骼闪烁扫描及一些骨转换标志物在血液透析患者肾性骨营养不良诊断中的应用]
Pol Arch Med Wewn. 2003 Sep;110(3):943-50.
2
The impact of chronic inflammation on bone turnover in hemodialysis patients.慢性炎症对血液透析患者骨转换的影响。
Ren Fail. 2008;30(4):431-7. doi: 10.1080/08860220801964251.
3
Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children.骨转换生化标志物在透析儿童肾性骨营养不良诊断中的应用
Turk J Pediatr. 2004 Jan-Mar;46(1):28-31.
4
Procollagen I carboxyterminal propeptide (PICP) as a bone formation marker and carboxyterminal telopeptide of type I collagen (ICTP) as a bone degradation marker in children with chronic renal failure under conservative therapy.在接受保守治疗的慢性肾衰竭儿童中,I型前胶原羧基末端前肽(PICP)作为骨形成标志物,I型胶原羧基末端端肽(ICTP)作为骨降解标志物。
Med Sci Monit. 2003 Jan;9(1):CR19-23.
5
Renal osteodystrophy in Ramathibodi Hospital: histomorphometry and clinical correlation.拉玛蒂博迪医院的肾性骨营养不良:组织形态计量学与临床相关性
J Med Assoc Thai. 2000 Oct;83(10):1223-32.
6
Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.骨闪烁显像与骨标志物在肺癌患者骨转移诊断中的比较。
Anticancer Res. 2004 Sep-Oct;24(5B):3193-201.
7
Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.12个月重组生长激素治疗对慢性血液透析患者骨代谢参数和骨矿物质密度的影响。
J Nephrol. 2004 Jan-Feb;17(1):87-94.
8
[Study of renal osteodystrophy by bone biopsy. Age as an independent factor. Diagnostic value of bone remodeling markers].[通过骨活检研究肾性骨营养不良。年龄作为独立因素。骨重塑标志物的诊断价值]
Nefrologia. 2000 Jul-Aug;20(4):362-72.
9
Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients.骨标志物在血液透析患者低转换型骨营养不良诊断中的应用
Nephrol Dial Transplant. 1998 Sep;13(9):2294-302. doi: 10.1093/ndt/13.9.2294.
10
Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients.血清I型胶原C末端肽水平:血液透析患者皮质骨丢失的一种有用新标志物。
Osteoporos Int. 2005 May;16(5):501-9. doi: 10.1007/s00198-004-1712-4. Epub 2004 Aug 11.

引用本文的文献

1
Noninvasive assessment of bone health in Indian patients with chronic kidney disease.印度慢性肾脏病患者骨健康的无创评估
Indian J Nephrol. 2013 May;23(3):161-7. doi: 10.4103/0971-4065.111831.